Clinical trial
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
NCT06147154 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2022
- Completion date
- December 31, 2022
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic ductal adenocarcinoma (pdac)